24.6 C
New York
Sunday, June 14, 2026

Tag: market dynamics

Simpson Manufacturing Co., Inc. Announces 2025 Second Quarter Financial Results and Reaffirms 2025 Guidance

Net sales of $631.1 million increased 5.7% year-over-yearIncome from operations of $140.2 million increased 6.1% year-over-yearNet income per diluted share of $2.47 increased 6.9%...

Data Center Market to Grow at a CAGR of 11.51% from 2025 to 2032 | SkyQuest Technology Consulting

WESTFORD, Mass., July 28, 2025 /PRNewswire/ -- SkyQuest Technology Consulting published a report, titled, Data Center Market- Global Opportunity Analysis and Industry Forecast, 2025-2032",...

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12 (the “Reverse Stock Split”). The Company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025 under the existing symbol of “CLDI.” The new CUSIP number for the Company’s common stock following the Reverse Stock Split will be 320703 408.

Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030

"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON,...

Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030

"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON,...

Federal Reserve Maintains Interest Rates—Implications for Strategic Financial Planning

As the Federal Reserve approaches its upcoming meeting, the dynamics between President Donald Trump and Fed Chair Jerome Powell have become notably strained. President...

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

First American Properties CEO Michael Eisenga Issues Statement on June Housing Market Trends: “Momentum Shifting Toward Buyers Amid Unusual Mid-Year Softness”

COLUMBUS, Wis., July 24, 2025 (GLOBE NEWSWIRE) -- In a market update released today, Michael Eisenga, CEO of First American Properties LLC, addressed significant trends emerging in the U.S. housing sector for the month of June. Citing a confluence of weakening price trends, rising inventory, and a pullback in single-family home construction, Eisenga emphasized that the second half of 2025 may mark a structural shift in market dynamics—offering buyers more leverage than at any point in the past two years.

China-SpaceX Competitive Analysis: Evaluating Strategic Advances in Aerospace Market Dynamics

China has prioritized advancing its satellite capabilities to rival SpaceX's comprehensive Starlink network, which currently boasts nearly 8,000 low-Earth orbit (LEO) satellites. From a...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMarket dynamics